Women's Health

The FDA recently granted 510(k) clearance for Jada System, a device its manufacturer said “rapidly controls and treats postpartum hemorrhage and abnormal postpartum uterine bleeding.”

Sex disparities continue in CV scientific leadership, as women are not often present in leadership roles of CV clinical trials published in major journals, researchers found.

Cardiologists and clinicians do not often recognize the sex-specific CVD pathophysiology in women, especially when using imaging modalities to diagnose patients, according to a speaker.

Menopause can be a good time to start addressing CVD risk reduction even though it should be discussed way before then, according to a presentation at the virtual Heart in Diabetes Conference.

Women with peripheral artery disease were more likely to have depressive symptoms compared with men, researchers found.

There are many ways in which women’s CV risk differs from that of men, and addressing it requires solutions tailored to women, according to a presentation at the virtual American Society for Preventive Cardiology Congress on CVD Prevention.

CVD is the leading cause of maternal deaths in the U.S., contributing to a more than twofold increase in pregnancy-related mortality from 1987 to 2015, and better CV management in pregnant women is needed, according to a presenter.

Obstructive CAD is not always the best predictor of CV events, especially in women, so a better characterization of coronary pathophysiology is necessary, according to a speaker.

For young women who want to improve their aerobic fitness, weight loss may not matter, researchers found.

In a survey of cardiac clinicians, researchers found that neither sex nor race of a patient predicted allocation of HF therapies, although bias was observed in the form of harsher judgment of women overall, particularly for Black women.